Earlier, New York Times reported Russian figure skater Kamila Valieva was found to have three drugs that can be used to treat heart conditions in her sample she provided last December though her doping case has rocked the Beijing Olympics.
Besides being banned for angina drug trimetazidine, the New York Times disclosed that the laboratory in Stockholm where Valieva’s sample was analyzed detected evidence of hypoxen and L-Carnitine, which aren’t on Olympics Games banned drug list.
Valieva’s recent arbitration hearing was recorded in documents provided to The New York Times by a participant in the hearing.
“It’s a trifecta of substances — two of which are allowed, and one that is not,” said Travis Tygart, chief executive of United States Anti-Doping Agency.
According to Reuters report, Tygart explained that such a combination would “seem to be aimed at increasing endurance, reducing fatigue and promoting greater efficiency in using oxygen.”
Reuters’ email to the Russian Olympic Committee did not receive an immediate response.
Despite a doping scandal that soured her Olympic career, Valieva, 15, dominated the women’s event on Tuesday with an emotional performance that advanced her in the hunt for an unlikely-to-be-awarded gold medal at the Beijing Olympics.
Valieva had tested positive on Dec. 25 during her national championships, but her results were not revealed until Feb. 8, when she had already competed in the Olympics games team event at the Beijing.
Read More: Ice cream company recalls all of its products due to the possibility of Listeria contamination.
Her drug case was not addressed by CAS, and now awaits a RUSADA hearing, which is not expected to hold until the Winter Games are over.
